Seres Therapeutics, Inc.
Public company- Headquarters
- CAMBRIDGE, Massachusetts
- Ticker
- MCRB
- CIK
- 0001609809
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOMarella Thorell | Oct 26, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
CFO departs: Marella Thorell
Marella Thorell, Executive Vice President and Chief Financial Officer of Seres Therapeutics, Inc., resigns the role, effective November 15, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 26, 2026Role: Executive Vice President and Chief Financial Officer
Only one public record so far. We add events as soon as a new filing lands; watch Seres Therapeutics, Inc. to get them in your digest.
Last verified Nov 8, 2026